AMLX Operating Income Growth
Amylyx Pharmaceuticals Inc · Operating Income Growth
AMLX Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported17.70%period ending
AMLX TTM Operating Income YoY % (-193.91% → 17.70%)
Year-over-year change
High-resolution chart · PNG
AMLX operating income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Income Growth |
|---|---|
| 17.7033% | |
| 23.2639% | |
| 47.4812% | |
| 36.8849% | |
| -27.1537% | |
| -155.3713% | |
| -852.2293% | |
| -3,127.0809% | |
| -90.9511% | |
| 47.76% | |
| 119.2718% | |
| 95.8257% | |
| 47.0802% | |
| -32.2577% | |
| -143.4948% | |
| -193.9141% |